Italian contrast firm Bracco said that results from the Patients with Renal Impairment and Diabetes undergoing CT (PREDICT) trial show no statistically significant difference between its Isovue-370 low-osmolar CT contrast agent and the Visipaque 320 isomolar agent (GE Healthcare, Chalfont St. Giles, U.K.) in the rate of contrast-induced nephropathy in high-risk patients undergoing CT studies.
The results were recently published in the American Journal of Roentgenology, according to Bracco of Milan.
Related Reading
Bracco completes E-Z-EM acquisition, April 2, 2008
Bracco to acquire E-Z-EM, October 30, 2007
Bracco, ImaRx sign licensing pact, July 4, 2007
Copyright © 2008 AuntMinnie.com
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
